dihydrolipoamide dehydrogenase

Preferred Label : dihydrolipoamide dehydrogenase;

MeSH definition : A flavoprotein containing oxidoreductase that catalyzes the reduction of lipoamide by NADH to yield dihydrolipoamide and NAD . The enzyme is a component of several MULTIENZYME COMPLEXES.;

MeSH synonym : diaphorase (lipoamide dehydrogenase); dehydrogenase, lipoic acid; dihydrolipoyl dehydrogenase; glycine decarboxylase complex l-protein; diaphorase, nadh; lipoic acid dehydrogenase; dehydrogenase, dihydrolipoamide; dehydrogenase, dihydrolipoyl; glycine decarboxylase complex l protein; nadh diaphorase; lipoamide dehydrogenase; dehydrogenase, lipoamide; lipoyl dehydrogenase; dehydrogenase, lipoyl; nad diaphorase; diaphorase, nad; l-protein, glycine decarboxylase complex;

MeSH hyponym : valine lipoamide dehydrogenase; Dehydrogenase, Valine Lipoamide; Lipoamide Dehydrogenase, Valine;

MeSH CAS label : dihydrolipoamide: NAD oxidoreductase;

MeSH Related Number : valine lipoamide dehydrogenase; EC 1.8.1.4;

Registry Number MeSH : EC 1.8.1.4;

Related CAS MeSH : EC 1.8.1.4 (Valine lipoamide dehydrogenase);

Is substance : O;

UNII : EC 1.8.1.4;

Details

Origin ID

D008058;

UMLS CUI

C0023783;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Dihydrolipoamide dehydrogenase [LOINC component]
- Dihydrolipoamide dehydrogenase (substance) [SNOMED CT concept]
- dihydrolipoamide dehydrogenase [SNOMED Notion]
False automatic mappings
- Leukocyte adhesion deficiency [ORDO Disease]
- dispensation assistance software [EFMI term]
Indexing information
- 2,3-diphenyl-1,4-naphthoquinone [MeSH Supplementary Concept]
- 2-(2-amino-5-bromo-N-methylpyridine-3-sulfonamido)-N-(4-methoxyphenyl)acetamide [MeSH Supplementary Concept]
- 4-aminophenyldichloroarsine [MeSH Supplementary Concept]
- methanearsonous acid [MeSH Supplementary Concept]
- phenylarsonous acid [MeSH Supplementary Concept]
Record concept(s)
- dihydrolipoamide dehydrogenase [MeSH concept]
- valine lipoamide dehydrogenase [MeSH concept]
Related MeSH Supplementary Concept(s)
- lpd protein, E coli [MeSH Supplementary Concept]
- mtLPD1 protein, Arabidopsis [MeSH Supplementary Concept]
- mtLPD2 protein, Arabidopsis [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
UMLS correspondences (same concept)
- Dihydrolipoamide dehydrogenase [LOINC component]
- Dihydrolipoamide dehydrogenase (substance) [SNOMED CT concept]
- dihydrolipoamide dehydrogenase [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients